Studies genes in people with and without blood cancers
Collects saliva samples and surveys to study genes linked to blood cancers.
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- Piscataway, United StatesSee the site
- Trial code
- Registry title
- Rutgers University Study of the Genetics of Blood Cancers
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 22 Sept 2026
- Expected to end
- Aug 2029
- Type of study
- Observational, 2 groups
- Record updated
- 1 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in the United States, with or without a blood cancer, who will take surveys online and give a saliva sample by mail for DNA testing.
- Age
- 18 years or older (up to 110 years)
- Sex
- All
Main reasons for not taking part
- Living outside the United States
- No access to the internet and a computer, laptop, tablet or smartphone
- Not willing to give written informed consent
- Not willing to give a saliva sample for DNA with a kit mailed to your home
- Not willing to complete a health survey about blood cancer
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- age 18 years or older
- currently living in the United States
- have access to the internet and a computer, laptop, tablet or smartphone
- willing to provide written informed consent for participation
- willing to provide DNA via a saliva sample using a collection kit mailed to your home
- willing to complete a survey with questions about health related to the study of blood cancer
Who cannot take part
- Not able to meet or fulfill any of the inclusion criteria
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 110 years old?
Where in United States
- Rutgers UniversityPiscataway, United StatesContact: Tara Matise, PhDTaking people
About the trial
What the trial wants to find out
The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.
The 2 groups in the trial
- Cases
Persons with blood cancer
- Controls
Persons who do not have blood cancer
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Rutgers University Study of the Genetics of Blood Cancers
- Plain-language title
- Studies genes in people with and without blood cancersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07714044, who can take part
- Record updated
- 1 October 2026